No Data
No Data
No Data
No Data
No Data
Express News | Innoviva Specialty Announced That Positive Results From The Phase 3 Oral Zoliflodacin Trial Will Be Highlighted In An Oral Presentation At The European Society Of Clinical Microbiology And Infectious Disease Global Congress
Moomoo 24/7Apr 24 07:12 ET
Innoviva Specialty Therapeutics' Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
PDF Version Single-dose, oral zoliflodacin achieved 90.9% microbiological cure rate, demonstrating statistical non-inferiority compared to current global standard of care Pivotal Phase 3 data
InnovivaApr 24 00:00 ET
Should Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Yahoo FinanceApr 22 11:36 ET
Analysts Offer Insights on Healthcare Companies: Lonza Group Ltd (Six Swiss: CH:LONN), Harrow Health (HROW) and Innoviva (INVA)
TipRanksApr 3 05:04 ET
Express News | Armata Pharmaceuticals Enters Secured Credit Agreement With Innoviva Strategic Opportunities, A Wholly-owned Subsidiary Of Innoviva
Moomoo 24/7Mar 4 16:03 ET
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
On February 29, 2024, Innoviva Inc (NASDAQ:INVA) released its 8-K filing, detailing its financial performance for the fourth quarter and the full year of 2023.
Yahoo FinanceFeb 29 16:37 ET
No Data
No Data